ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Muscle Biology, Myositis and Myopathies: Myositis Autoantibodies and Disease Phenotype

Meeting: 2014 ACR/ARHP Annual Meeting

Abstract Number: 1255
Pathogenic Role of Tyrosyl–Transfer RNA Synthetase in Anti-Synthetase Syndrome
Abstract Number: 1256
Clinical and Temporal Characterization of Anti-Jo-1 Positive Anti-Synthetase Syndrome: Preliminary Results of an International Multicentre Study
Abstract Number: 1257
A New Multianalyte Assay for Detection of Dermatomyositis-Specific Autoantibodies Undetectable By Commercially Available Immunoassays
Abstract Number: 1258
Enzyme-Linked Immunosorbent Assays for Detection of Anti-Transcriptional Intermediary Factor-1 Gamma and Anti-Mi-2 Autoantibodies in Dermatomyositis: Utility and Crossreactivity
Abstract Number: 1259
A Multi-Center Study for Validation of a New Assay for Anti-Melanoma Differentiation-Associated Gene 5 (MDA5) Autoantibody
Abstract Number: 1260
The Early Use of Cyclosporine Is Beneficial for Long-Term Prognosis in Patients of Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease with Anti- Synthetase Antibodies
Abstract Number: 1261
Pulmonary Arterial Hypertension in Patients with Anti-PM-Scl Antibody
Abstract Number: 1262
Mechanisms of Muscular Necrosis in Auto-Immune Myopathies Associated with Anti-Signal Recognition Particle and Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Antibodies: Pathogenic Role of Auto-Antibodies
Abstract Number: 1263
Evidence for the Involvement of NK Cells in Antisynthetase Syndrome
Abstract Number: 1264
Analysis of Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Severity of Physical Dysfunction after Treatment for Polymyositis and Dermatomyositis
Abstract Number: 1265
Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase
Abstract Number: 1266
Anti-MDA5 Is Associated with Rapidly-Progressive Interstitial Lung Disease and Poor Survival in U.S. Patients with Amyopathic and Myopathic Dermatomyositis
Abstract Number: 1267
Are Anti-SRP Auto-Antibodies Specific for Myositis?
Abstract Number: 1268
Study of Autoantibodies in a cohort of Mexican patients with idiopathic inflammatory myopathies
Abstract Number: 1269
Epidemiology and Characteristics of Antisynthetase Syndrome in the African Descent Population of Martinique
Abstract Number: 1270
Distinctive Muscle Histopathological Features of Anti-Synthetase Syndrome
Abstract Number: 1271
Myocarditis in Antisynthetase Syndrome
Abstract Number: 1272
Myositis-Specific and Myositis Associated Autoantibodies in Indian Patients with Inflammatory Myositis
Abstract Number: 1273
Assessment of the Effect of Rituximab in the Treatment of Interstitial Lung Disease  associated with the Antisynthetase Syndrome

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences